The shareholders of Delta Med S.r.l., a Mantua-based company active in the production and marketing of disposable cannula needles for hospitals and health centers, have opened their capital to the entry of a financial partner to support the company's various development plans. The operating partners, while retaining a significant share and operational management of the company, carried out a Management Buy Out transaction with a group of private equity funds, led by Cape Natexis Private Equity Fund (hereafter CNPEF), a fund under Italian law that specializes in investments in small and medium-sized companies.

Delta Med was assisted in the transaction by K Finance and the law firm, Macchi Di Cellere and Gangemi.

CNPEF was assisted for legal aspects by Studio Marena, Bonvicini, Aghina and Ludergnani.

The main objective of the financial partner entry transaction is to support the worldwide diffusion of the company's newly patented safety cannula needle. The entry of the CNPEF fund will also allow the company to leverage its expertise in China to further develop its business in the promising Far East markets.

Delta Med, founded in 1994, has been experiencing steadily growing sales in recent years. The company's main product is cannula needles of different sizes and characteristics, usually used in infusion therapies needed in hospitals and health centers. Enriching the company's offerings is a wide range of accessories complementary to infusion therapies.